Penumbra

$272.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.01%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Penumbra and other stocks, options, and ETFs commission-free!

About PEN

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products.

CEO
Adam Elsesser
Employees
3,300
Headquarters
Alameda, California
Founded
2004
Market Cap
9.99B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
239.85K
High Today
$275.66
Low Today
$266.56
Open Price
$272.37
Volume
248.04K
52 Week High
$314.22
52 Week Low
$153.79

PEN Earnings

-$0.39
-$0.12
$0.15
$0.42
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

EVOJU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure